Navigation Links
DuPont Strengthens Leading Biotechnology Position with Leadership Changes

Company Addressing Growing Global Demand for Biotech-Based Materials, Fuel,

Food, Feed

WILMINGTON, Del., Feb. 27 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) today announced leadership changes to strengthen its leading biotechnology position and better serve the growing global demand for the company's biotech- based innovations in materials, food, feed and fuel markets.

"Across its business segments, DuPont is integrating biology with its expertise in chemistry to deliver its biotechnology pipeline to the marketplace. DuPont has stepped up its efforts, including today's leadership changes, to accelerate commercialization of its bio-based technologies to meet growing global demand," said DuPont Chairman and CEO Charles O. Holliday, Jr.

"Population growth, rising income and demand for bio-based products are driving increased demand for biotechnology outputs," Holliday said. "DuPont is uniquely positioned to meet the challenge due to our multi-discipline science and ability to integrate biology across our business segments and different industries."

DuPont is developing a broad range of innovations using both biology and chemistry to provide customers with superior performing products, including:

-- A portfolio of renewably-sourced polymers, providing better or

comparable performance than petrochemical-based alternatives, including

DuPont(TM) Sorona(R) EP thermoplastic resins and DuPont(TM) Hytrel(R)

RS thermoplastic elastomers;

-- Imron(R) polyurethane enamels, made with DuPont(TM) Cerenol(TM) polyol,

providing superior durability, gloss and color retention;

-- Pro-Cote(R) soy polymers, a renewably-sourced material derived from

soybeans, for multiple adhesive applications in various industries

including construction and publishing;

-- Advanced biofuels -- including cellulosic-based and biobutanol --

providing improved performance and options for expanding the world's

energy supplies.

"The synergies among multiple biotechnology markets -- including materials, coatings, agriculture and biofuels -- are creating potential game- changing solutions to the world's most difficult challenges and significant growth opportunities for DuPont," Holliday said. "Today, we enhanced our already strong leadership position in providing sustainable solutions to the global marketplace."
DuPont's leadership changes effective today include:

-- Thomas M. Connelly, 55, executive vice president, will lead the

integration of biotechnology across the company's business segments.

He assumes responsibility for the DuPont Agriculture & Nutrition

business segment in addition to his existing responsibilities.

-- James C. Borel, 52, senior vice president -- DuPont Human Resources, is

named group vice president, leading the company's production

agriculture businesses. From 1997-2004, Borel was vice president and

general manager -- DuPont Crop Protection. He has held a range of

agricultural leadership positions in DuPont, including leading the

company's agricultural products business in Canada and Asia Pacific

during his 23-year career in agriculture. Borel, an Iowa State

graduate with a degree in agriculture business, serves on the National

4-H Board of Trustees.

-- J. Erik Fyrwald, 48, group vice president -- DuPont Agriculture &

Nutrition, has resigned from the company to pursue other interests.

-- Craig F. Binetti, 52, president of DuPont Nutrition & Health, will

continue as chairman of the Solae Company, a joint venture with the

Bunge Corporation that provides soy protein to the global marketplace,

in addition to leading the food ingredient and food safety businesses

for DuPont.

-- Torkel Rhenman, 44, global business director -- DuPont Packaging &

Industrial Polymers, is named CEO of Solae. Rhenman has broad global

business experiences, including a strong background in joint ventures

from previous assignments.

-- W. Donald Johnson, 60, chairman and representative director -- DuPont

K.K. (Japan), is named senior vice president -- DuPont Human Resources,

responsible for the global strategic direction of the company's human

resources function. His successor in Japan will be named later.

-- Maritza J. Poza-Grise, 49, director -- DuPont Human Resources, is named

vice president -- DuPont Human Resources. She will be responsible for

executing the company's human resources strategies globally.

Last month, DuPont named Nicholas C. Fanandakis group vice president - DuPont Applied BioSciences. In this newly created position, Fanandakis is leading Applied BioSciences' accelerated efforts to commercialize a range of bio-based products and technologies, including biofuels and biomaterials.

Complete biographies and photos are available at:

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.


The DuPont Oval Logo, DuPont(TM), The miracles of science(TM), Sorona(R), Hytrel(R), Imron(R), Cerenol(TM), Pro-Cote(R), are registered trademarks or trademarks of DuPont or its affiliates.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
2. DuPont Pledges $1 Million to World Food Prize
3. DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity
4. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
5. DuPont Announces Leadership Changes
6. DuPont Opens Fluoropolymer Production Plant in China
7. DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker
8. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
9. DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber
10. DuPont Names Phuong Tram Chief Information Officer
11. DuPont Group Vice President Briefs Investors on Performance Materials Segment
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... Trustify is proud to announce the success of the seventh ... organization dedicated to ending domestic violence. , Trustify and Becky’s Fund have joined forces ... of domestic violence. Trustify is also proud to announce the launch of the company’s ...
(Date:12/1/2015)... ... December 01, 2015 , ... Henderson, ... Tennessee to receive Gigabit Internet through a partnership this year with Aeneas Internet ... Henderson is an attractive destination for entrepreneurs who want to build a business. ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... ... 2015 , ... It’s official: Tattoo taboo is a thing of the past. ... Millennials (a whopping one in three aged 18 to 25 is inked). As tattoos ... their ink. In fact, RealSelf , the world’s largest community for learning and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Contraceptives ... Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, ... Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) ... Trends and Forecast 2014 - 2020 ", ... (TMR).The report states that the global contraceptives ...
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... 2015  InCarda Therapeutics, Inc. (InCarda), a privately-held biopharmaceutical ... for cardiovascular conditions via the inhalation route, today announced ... Australia . InCarda is planning to undertake ... in the first half of 2016. The ... in Adelaide and Melbourne.  In ...
Breaking Medicine Technology: